Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

The Conversation

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday

Eli Lilly was an S&P 500 top performer Monday, while energy plays were among the day's biggest winners and losers.

Investors Business Daily

Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump

“There’s a true organic growth opportunity here,” Jamey Mock says.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors Business Daily

The Dreaded Market Crash Is Already Here For 14 Stocks

Investors fearing a brutal stock market crash are still waiting with dread. But it's already arrived for a group of battered S&P 500 stocks.

Investors Business Daily

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Barchart

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Stock Market Remains Steadfast; Data Analytics Stock Pops On Upgrade

The stock market remained positive with the major indexes all gaining around 1%. Retail stock rises on news it will get added to the S&P 500 Index.

Investors Business Daily

Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion

Moderna stock and BioNTech stock led a sell-off Monday among Covid vaccine makers after Pfizer slashed its full-year guidance.

Investors Business Daily

Flu-COVID combo vaccines on the horizon

Moderna announces plans to move a novel vaccine design into its final stage of development

Salon

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Salon

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna

The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.

Investors Business Daily

US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Independent UK

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The Hindu

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Tenacious curiosity in the lab can lead to a Nobel Prize – mRNA research exemplifies the unpredictable value of basic scientific research

The 2023 Nobel Prize in physiology or medicine will go to Katalin Karikó and Drew Weissman for their discovery that modifying mRNA – a form of genetic material your body uses to produce proteins – could reduce unwanted inflammatory responses and allow it to be delivered into cells. While the…

The Independent UK

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Conversation

Nobel prize in medicine awarded to mRNA pioneers – here's how their discovery was integral to COVID vaccine development

Billions of people around the world have received the Pfizer or Moderna COVID-19 vaccines. The rapid development of these vaccines changed the course of the pandemic, providing protection against the SARS-CoV-2 virus.

The Hindu

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues

Pfizer and Moderna say they have sent out millions of doses of the new COVID-19 vaccines in the past week

The Conversation

A COVID inquiry has been announced. But is COVID still a thing? Do I need a booster?

Today’s announcement of an independent inquiry into Australia’s COVID response will examine how we’ve handled the pandemic and how we could better prepare for the next one.

The Independent UK

Updated Covid vaccines from Pfizer and Moderna rolled out nationwide: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Guardian - US

The new Covid-19 booster shot in the US: what you need to know

US authorities have approved a vaccine that protects from one of the most widely circulating strains of coronavirus

Fortune

COVID levels are so high, they're approaching 2020's initial peak, as the WHO urges those at high risk to take any booster they can get their hands on

It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it.

Salon

CDC recommends new COVID boosters

The virus sometimes causes severe illness even in those without underlying conditions, including deaths in children

Fortune

Moderna's COVID shots will grow revenue by $8 billion this year. But the company's CFO has his eye on other targets

Moderna plans on investing $25 billion in research and development from 2024 through 2028.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.